ArticleImmunoTargets and therapy2024

The Efficacy and Safety of Bevacizumab Plus Anti-PD-1/PD-L1 Inhibitors in Combination with Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma.

Xiang Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.